Specter of Shkreli Looms over Trump HHS Pick, Under Barrage of Criticism for Eli Lily Price Hikes
President Trump’s second pick to run the Department of Health and Human Services acknowledged that he oversaw the jacking up of drug prices, as as a pharmaceutical executive. Alex Azar deflected criticism from Democrats on Tuesday, while testifying before the Senate Finance Committee. The nominee said high prices were a systemic problem, and that he wasn’t personally responsible for the trend, as the former President of Eli Lily. “I don’t know that there is any drug price of a branded product that has ever gone…